These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25387598)

  • 1. Prior authorization in the treatment of patients with pDPN and FM.
    Placzek HE; Masters ET; Gu T; Cappelleri JC; Wasser TE; Clair AG; Cook JP; Eisenberg DF
    Pain Pract; 2015 Jan; 15(1):E9-19. PubMed ID: 25387598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.
    Udall M; Louder A; Suehs BT; Cappelleri JC; Joshi AV; Patel NC
    J Med Econ; 2013; 16(6):784-92. PubMed ID: 23565813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
    Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B
    BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans.
    Margolis JM; Cao Z; Onukwugha E; Sanchez RJ; Alvir J; Joshi AV; Mullins CD
    Am J Manag Care; 2010 Jun; 16(6):447-56. PubMed ID: 20560688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
    Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
    Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of pharmacoeconomic studies for pregabalin.
    Parker L; Huelin R; Khankhel Z; Wasiak R; Mould J
    Pain Pract; 2015 Jan; 15(1):82-94. PubMed ID: 24815038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment.
    Udall M; Mardekian J; Cabrera J
    Pain Pract; 2013 Jul; 13(6):476-84. PubMed ID: 23150918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the effectiveness of policies restricting access to pregabalin.
    Stacey BR; Liss J; Behar R; Sadosky A; Parsons B; Masters ET; Hlavacek P
    BMC Health Serv Res; 2017 Aug; 17(1):600. PubMed ID: 28841868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine.
    Margolis J; Cao Z; Fowler R; Harnett J; Sanchez RJ; Mardekian J; Silverman SL
    J Med Econ; 2010; 13(4):738-47. PubMed ID: 21091395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
    Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D
    Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
    Marlow NM; Simpson KN; Vaughn IA; Jo A; Zoller JS; Short EB
    Pain Pract; 2018 Feb; 18(2):154-169. PubMed ID: 28419725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
    Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
    Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J; Margolis J; Cao Z; Fowler R; Sanchez RJ; Mardekian J; Silverman SL
    Pain Pract; 2011; 11(3):217-29. PubMed ID: 21199319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
    Carlos F; Espejel L; Novick D; López R; Flores D
    Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy.
    Sadosky A; Mardekian J; Parsons B; Hopps M; Bienen EJ; Markman J
    J Diabetes Complications; 2015 Mar; 29(2):212-7. PubMed ID: 25498300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Jan; 12(1):14-22. PubMed ID: 21615857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.
    Chen S; Wu N; Boulanger L; Fraser K; Zhao Z; Zhao Y
    J Med Econ; 2011; 14(4):411-20. PubMed ID: 21615268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.